We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
Submission dates and how the submissions using the EC decision reliance procedure work.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
The CMA is investigating whether Google might have abused a dominant position through its conduct in ad tech
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
How to apply for marketing authorisation via this new procedure.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
How to renew marketing authorisations for products granted through different routes and at different times.
A keynote speech by Martin Coleman, Non-Executive Director and Panel Chair of the Competition and Markets Authority (CMA), to the Swedish Competition Authority’s Pros and Cons Conference.
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
How to use chatbots and webchat tools to improve your users’ experience of your service.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
Guidance for holders of Marketing Authorisations approved in Northern Ireland or the EU/EEA member states who want to bring a product to market in Great Britain.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).